Loading patent…
OwnerCharanjit Behl, Vincent D. Romeo +5inventors
InventorsCharanjit Behl, Vincent D. Romeo, Raja Achari, Shamin Ahmed, Jorge deMeireles, Tianquing Liu, Anthony Sileno
Estimating the term…
Intranasal delivery compositions and methods for the delivery of dopamine receptor agonists are provided which are effective for the treatment14 of sexual dysfunction in a mammal without causing substantial intolerable adverse side effects to the mammal, in particular adverse nasal effects. Nasally administered compositions for treating sexual dysfunction in a mammal are also provided which include a therapeutically effective amount of a dopamine receptor agonist which has been dispersed in a system to improve its solubility and/or stability.
A nasally administered pharmaceutical composition for treating sexual dysfunction in a mammal comprising a therapeutically effective amount of a dopamine receptor agonist in combination with a glycol derivative wherein incidence of adverse nasal effects of said mammal is reduced.
A nasally administered pharmaceutical composition for treating sexual dysfunction in a mammal comprising a therapeutically effective amount of a dopamine receptor agonist in combination with propylene glycol.
A method of treating sexual dysfunction in a mammal comprising nasally administering a therapeutically effective amount of a dopamine receptor agonist in combination with a glycol derivative before, during or after sexual activity, wherein incidence of adverse nasal effects of said mammal is reduced.
A method of increasing sexual desire of a female or male mammal comprising nasally administering a therapeutically effective amount of a dopamine receptor agonist in combination with a glycol derivative before, during or after sexual activity wherein incidence of adverse nasal effects of said mammal are reduced to said mammal.
A method of increasing sexual arousal in a female or male mammal comprising nasally administering a therapeutically effective amount of a dopamine receptor agonist to said mammal before, during or after sexual activity.
A method of reducing dyspareumia in a female mammal comprising nasally administering a therapeutically effective amount of a dopamine receptor agonist to said mammal before, during or after sexual activity.
A method of reducing difficulty in achieving or inability of achieving orgasm in a female mammal comprising nasally administering a therapeutically effective amount of a dopamine receptor agonist to said mammal before, during or after sexual activity.
Dependencies are inferred from the claim text.